S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
Log in

NASDAQ:NSTGNanoString Technologies Stock Price, Forecast & News

$37.34
+1.59 (+4.45 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$36.13
Now: $37.34
$37.50
50-Day Range
$28.84
MA: $34.15
$37.55
52-Week Range
$13.85
Now: $37.34
$38.40
Volume199,141 shs
Average Volume520,884 shs
Market Capitalization$1.41 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.36
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, CAR-T characterization, protein immune profiling, neuropathology and neuro-inflammation gene expression, Mouse-AD, autoimmune disease gene expression, miRNA expression, and other gene expression panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc, as well as strategic partnership with Bio-Techne Corp. The company was founded in 2003 and is headquartered in Seattle, Washington.
Read More
NanoString Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.95 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$125.57 million
Book Value$2.91 per share

Profitability

Net Income$-40,700,000.00

Miscellaneous

Employees476
Market Cap$1.41 billion
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$37.34
+1.59 (+4.45 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

How has NanoString Technologies' stock been impacted by COVID-19 (Coronavirus)?

NanoString Technologies' stock was trading at $30.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NSTG stock has increased by 22.4% and is now trading at $37.34.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of NanoString Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for NanoString Technologies
.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for NanoString Technologies
.

How can I listen to NanoString Technologies' earnings call?

NanoString Technologies will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies Inc (NASDAQ:NSTG) announced its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.52) by $0.33. The biotechnology company earned $26.61 million during the quarter, compared to analysts' expectations of $24.67 million. NanoString Technologies had a negative net margin of 46.13% and a negative return on equity of 73.44%.
View NanoString Technologies' earnings history
.

What price target have analysts set for NSTG?

3 equities research analysts have issued 12-month target prices for NanoString Technologies' shares. Their forecasts range from $34.00 to $38.00. On average, they expect NanoString Technologies' share price to reach $35.67 in the next year. This suggests that the stock has a possible downside of 4.5%.
View analysts' price targets for NanoString Technologies
.

Has NanoString Technologies been receiving favorable news coverage?

News headlines about NSTG stock have trended somewhat negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. NanoString Technologies earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave media coverage about the biotechnology company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the next few days.
View the latest news about NanoString Technologies
.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank Of The Ozarks (OZRK) and Eaton Vance Floating-Rate Income Trust (EFT).

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 42)
  • Mr. K. Thomas Bailey M.B.A., CFO & Treasurer (Age 50)
  • Dr. Mary Tedd Allen, Sr. VP of Operations & Admin. (Age 56)
  • Dr. Joseph M. Beechem, Sr. VP of R&D (Age 61)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 52)

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (6.28%), Frontier Capital Management Co. LLC (1.03%), Columbus Circle Investors (0.68%), UBS Group AG (0.30%), Swiss National Bank (0.22%) and SG Americas Securities LLC (0.13%). Company insiders that own NanoString Technologies stock include Charles P Waite Jr, Charles P Waite, Jr, David W Ghesquiere, J Chad Brown, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, Nicholas Galakatos, R Bradley Gray, Robert Hershberg and William Young.
View institutional ownership trends for NanoString Technologies
.

Which major investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Frontier Capital Management Co. LLC, and Columbus Circle Investors. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite Jr, Charles P Waite, Jr, David W Ghesquiere, J Chad Brown, K Thomas Bailey, Kirk Malloy, R Bradley Gray, Robert Hershberg, and William Young.
View insider buying and selling activity for NanoString Technologies
.

Which major investors are buying NanoString Technologies stock?

NSTG stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Swiss National Bank, Fox Run Management L.L.C., ProShare Advisors LLC, SG Americas Securities LLC, Arizona State Retirement System, Exchange Traded Concepts LLC, and Conestoga Capital Advisors LLC.
View insider buying and selling activity for NanoString Technologies
.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $37.34.

How big of a company is NanoString Technologies?

NanoString Technologies has a market capitalization of $1.41 billion and generates $125.57 million in revenue each year. The biotechnology company earns $-40,700,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. NanoString Technologies employs 476 workers across the globe.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is www.nanostring.com.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.